These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 34171565)

  • 1. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.
    Rezaeifard S; Talei A; Shariat M; Erfani N
    Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell subsets and their functional molecules in peripheral blood of the patients with breast cancer.
    Darvishvand R; Rezaeifard S; Kiani R; Tahmasebi S; Faghih Z; Erfani N
    Immun Inflamm Dis; 2024 Apr; 12(4):e1255. PubMed ID: 38652012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
    Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
    J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome.
    Zhang Y; Zhao Y; Si W; Yang B; Lin M; Zheng J; Cui L
    Immunol Invest; 2022 Feb; 51(2):425-437. PubMed ID: 33103514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
    Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
    Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD16
    Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
    Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.
    Verma C; Kaewkangsadan V; Eremin JM; Cowley GP; Ilyas M; El-Sheemy MA; Eremin O
    J Transl Med; 2015 Jun; 13():180. PubMed ID: 26040463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with Bladder Cancer and Their Clinical Implications.
    Ariafar A; Kohansal E; Mousania A; Faghih Z
    Iran J Immunol; 2024 Jun; 21(2):121-131. PubMed ID: 38583001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.
    Messaoudene M; Fregni G; Fourmentraux-Neves E; Chanal J; Maubec E; Mazouz-Dorval S; Couturaud B; Girod A; Sastre-Garau X; Albert S; Guédon C; Deschamps L; Mitilian D; Cremer I; Jacquelot N; Rusakiewicz S; Zitvogel L; Avril MF; Caignard A
    Cancer Res; 2014 Jan; 74(1):81-92. PubMed ID: 24225017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating NK cells and their subsets in Behçet's disease.
    Hasan MS; Ryan PL; Bergmeier LA; Fortune F
    Clin Exp Immunol; 2017 May; 188(2):311-322. PubMed ID: 28170096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human peripheral blood CD56+ natural killer cell subsets and their phenotypic and biological properties].
    Wu CY; Liu J; Yang BY; Roedere M
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):169-72. PubMed ID: 16875598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
    Laroni A; Armentani E; Kerlero de Rosbo N; Ivaldi F; Marcenaro E; Sivori S; Gandhi R; Weiner HL; Moretta A; Mancardi GL; Uccelli A
    J Autoimmun; 2016 Aug; 72():8-18. PubMed ID: 27157273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
    Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of CD56
    Arianfar E; Khandoozi SR; Mohammadi S; Memarian A
    Clin Transl Oncol; 2023 Mar; 25(3):841-851. PubMed ID: 36414921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.